Work

Venetoclax Combined with Three-Day Multi-Frequency Decitabine and Homoharringtonine (DEC3-VEN-HHT) As Induction Therapy in Newly Diagnosed Core-Binding Factor Acute Myeloid Leukemia

Year: 2024

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2024-202971

Authors: Lei Ju, Xingli Zhao, Xiaohui Suo, ZePing Zhou, Yanliang Bai, Yunya Luo, Sifeng Gao, Xinxiao Lu, Linyu Yuan, Congcong Zhang, Yinling Li, Yaxian Tan, Guanchen Bai, Hongling Peng, Pengxiang Guo, Yingchang Mi, Kaiqi Liu

Institutions: Qingdao University, Taian City Central Hospital, Tianjin People's Hospital, Kunming Medical University, Second Affiliated Hospital of Kunming Medical College, Zhengzhou University, Henan Provincial People's Hospital, Central South University, Second Xiangya Hospital of Central South University, Guizhou Provincial People's Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital, State Key Laboratory of Experimental Hematology

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4405040065

Cites:

Cited by: 1

Related to: 10